Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Jacobs

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
Urology|August 28, 2018
Excessive Opioid Prescribing After Major Urologic ProceduresKatherine M Theisen, John M Myrga, Nathan Hale, et al.
Urologic Oncology|December 14, 2020
Referral pattern for urologic malignancies before and during the COVID-19 pandemicAvinash Maganty, Michelle Yu, Vivian I Anyaeche, et al.
The Journal of Urology|October 23, 2013
Regional variation in quality of prostate cancer careFlorian R Schroeck, Samuel R Kaufman, Bruce L Jacobs, et al.
Urology|March 26, 2013
Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasiaFlorian R Schroeck, John M Hollingsworth, Brent K Hollenbeck, et al.
Urology|November 14, 2018
Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare AnalysisLee A Hugar, Jonathan G Yabes, Robert M Turner, et al.
Urologic Oncology|February 16, 2022
Corrigendum to 'The centralization of bladder cancer care and its implications for patient travel distance' [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9-834.e.20/9680]Kelly R Pekala, Jonathan G Yabes, Jathin Bandari, et al.
BMC Health Services Research|August 27, 2020
Radiation oncologists' attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancerBruce L Jacobs, Megan Hamm, Flor de Abril Cameron, et al.
JAMA Health Forum|March 28, 2025
High-Deductible Health Plan Enrollment and Prostate Cancer Screening RatesVanessa N Peña, Daisy Obiora, Chris Kypriotis, et al.
Urologic Oncology|January 13, 2022
Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registryAnup A Shah, ZhaoJun Sun, Kirsten Y Eom, et al.
Urologic Oncology|June 24, 2021
The centralization of bladder cancer care and its implications for patient travel distanceKelly R Pekala, Jonathan G Yabes, Jathin Bandari, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Urology|August 28, 2018
Excessive Opioid Prescribing After Major Urologic ProceduresKatherine M Theisen, John M Myrga, Nathan Hale, et al.
Urologic Oncology|December 14, 2020
Referral pattern for urologic malignancies before and during the COVID-19 pandemicAvinash Maganty, Michelle Yu, Vivian I Anyaeche, et al.
The Journal of Urology|October 23, 2013
Regional variation in quality of prostate cancer careFlorian R Schroeck, Samuel R Kaufman, Bruce L Jacobs, et al.
Urology|March 26, 2013
Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasiaFlorian R Schroeck, John M Hollingsworth, Brent K Hollenbeck, et al.
Urology|November 14, 2018
Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare AnalysisLee A Hugar, Jonathan G Yabes, Robert M Turner, et al.
Urologic Oncology|February 16, 2022
Corrigendum to 'The centralization of bladder cancer care and its implications for patient travel distance' [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9-834.e.20/9680]Kelly R Pekala, Jonathan G Yabes, Jathin Bandari, et al.
BMC Health Services Research|August 27, 2020
Radiation oncologists' attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancerBruce L Jacobs, Megan Hamm, Flor de Abril Cameron, et al.
JAMA Health Forum|March 28, 2025
High-Deductible Health Plan Enrollment and Prostate Cancer Screening RatesVanessa N Peña, Daisy Obiora, Chris Kypriotis, et al.
Urologic Oncology|January 13, 2022
Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registryAnup A Shah, ZhaoJun Sun, Kirsten Y Eom, et al.
Urologic Oncology|June 24, 2021
The centralization of bladder cancer care and its implications for patient travel distanceKelly R Pekala, Jonathan G Yabes, Jathin Bandari, et al.
Pageof 20